Quantitative analysis for GoodRx Holdings, Inc. (GDRX) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Buy (59.0) (grade B). 27 signals analyzed (23 differentiated alt-data).
GDRX stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-04-29 | $2.37 | $2.26 | $2.29 |
| 2026-05-11 | $3.00 | $2.81 | $2.84 |
| 2026-05-21 | $2.57 | $2.48 | $2.56 |
| 2026-06-03 | $2.96 | $2.73 | $2.81 |
| 2026-06-15 | $2.75 | $2.67 | $2.73 |
| 2026-06-26 | $2.83 | $2.64 | $2.80 |
| 2026-07-09 | $2.97 | $2.89 | $2.94 |
| 2026-07-21 | $3.13 | $2.99 | $3.02 |
| 2026-07-31 | $3.17 | $3.06 | $3.07 |
| 2026-08-12 | $3.81 | $3.57 | $3.59 |
| 2026-08-24 | $3.50 | $3.42 | $3.44 |
| 2026-09-03 | $3.58 | $3.46 | $3.53 |
How GoodRx Holdings, Inc. stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| INMD | InMode Ltd. | $888M | 50.0 |
| SPTX | Seaport Therapeutics, Inc. Common Stock | $837M | — |
| LXRX | Lexicon Pharmaceuticals, Inc. | $982M | — |
| DRTS | Alpha Tau Medical Ltd. | $984M | — |
View all Health Care stocks by valuation and signals →
GoodRx Holdings, Inc. (GDRX) scores Buy (59.0), with no measured dimension below 42. Its highest are competitive moat at 65, across 3 measured dimensions. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| competitive moat | 65 |
| technicals | 58 |
| analyst consensus | 42 |
StoQuant analyzes 27 signals (23 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on GoodRx Holdings, Inc. (GDRX): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/GDRX"><img src="https://stoquant.com/badge/GDRX.svg" alt="GoodRx Holdings, Inc. (GDRX) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.